‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms

Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.

US Capitol building on a cloudy day — • Source: Shutterstock

A stripped-down version of the US Food and Drug Administration user-fee reauthorization package, introduced in the Senate on 14 July, leaves out provisions for modernizing cosmetics oversight and strengthening dietary supplement regulations.

Sen. Richard Burr, R-NC, authored the FDA Simple Reauthorization Act as an antidote to the excessively amended FDA Safety and Landmark Advancements (FDASALA) Act, S

‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms

More from Legislation

More from Policy & Regulation